PD-L1 (+) and low NLR associated with better PFS. »
04/09/22

No difference in prevalence of founder mutations between cases and healthy controls. »
04/08/22

Patients without LVI and loss of expression of KCNQ1 had intermediate survival. »
04/08/22

Application of Enzalutamide after chemotherapy remained independent prognostic factor for worse OS. »
04/08/22

B7-H4 expression level significantly correlated with p-PKCδ level. »
04/11/22

No difference between AFG group and control. »
04/11/22

GNRI-low group showed significantly worse overall survival. »
04/11/22

NBCA-R dataset created by selecting RT parameters describing given dose, target volumes, coverage and homogeneity. »
04/12/22

Preservation of mitogen-independent phenotype in GSCs plays central role. »
04/12/22

microRNAs gaining increasing recognition as additional potential molecular markers in cardio-oncology field. »
04/12/22